Skip to main content

Table 2 Comparison of sociodemographic and clinical characteristics between type 2 diabetes patients with different MVCs

From: Achievement of treatment goals for secondary prevention of myocardial infarction or stroke in 29,325 patients with type 2 diabetes: a German/Austrian DPV-multicenter analysis

 

MI only (n = 15,015)

Stroke only (n = 11,738)

MI and stroke (n = 2572)

p*

n

 

n

 

n

 

Men,  %

15,015

63.0

11,738

50.1

2572

60.6

<0.0001

Age (years)

15,015

72.4 (65.1;78.8)

11,738

74.8 (67.9;81.0)

2572

74.8 (68.5;80.4)

<0.0001

Age at diagnosis (years)

15,015

60.9 (51.4;69.3)

11,738

63.9 (54.6;72.0)

2572

61.8 (52.0;70.0)

<0.0001

Diabetes duration (years)

15,015

9.6 (3.9;16.2)

11,738

9.6 (4.2;15.2)

2572

11.0 (6.2;19.2)

<0.0001

BMI (kg/m2)

13,887

29.2 (26.0;33.1)

9902

28.7 (25.5;32.7)

2255

29.1 (25.7;32.9)

<0.0001

HbA1C (%)

13,795

6.9 (6.2;8.1)

10,889

7.0 (6.2;8.3)

2407

7.1 (6.3;8.3)

<0.0001

Systolic BP (mmHg)

14,576

130.0 (120.0;140.0)

11,296

135.0 (120.0;149.0)

2496

130.0 (120.0;140.0)

<0.0001

Diastolic BP (mmHg)

14,562

74.0 (70.0;80.0)

11,287

80.0 (70.0;80.0)

2496

75.0 (70.0;80.0)

<0.0001

Total Chol (mg/dl)

12,750

166.0 (139.2;197.2)

8808

181.0 (150.0;216.0)

2087

169.0 (140.0;203.0)

<0.0001

LDL-Chol (mg/dl)

12,086

94.0 (73.0;121.0)

8245

107.9 (82.0;138.0)

1997

96.0 (73.0;126.0)

<0.0001

HDL-Chol (mg/dl)

12,176

41.0 (34.0;50.0)

8212

43.0 (35.0/52.0)

2001

41.0 (34.0;50.0)

<0.0001

Physical inactivity,  %

5217

90.4

4869

94.5

1207

93.3

<0.0001

Smoking, yes,  %

12,049

10.0

9189

8.8

2210

9.2

0.0173

Cigarettes per day

1200

15 (10;20)

809

15 (10;20)

201

15 (10;20)

0.1579

  1. Data are medians (Q1;Q3) unless otherwise indicated
  2. * p values adjusted for multiple comparisons by FDR